Personal information

No personal information available

Activities

Employment (2)

Boehringer Ingelheim Pharma GmbH and Co KG Biberach: Biberach, Baden-Württemberg, DE

2021-09-01 to present | Scientist PK/PD Modeling & Simulation
Employment
Source: Self-asserted source
Ferdinand Anton Weinelt

Freie Universität Berlin: Berlin, DE

2018-03-01 to 2021-08-31 | Doctoral student (Clinical Pharmacy & Biochemistry)
Employment
Source: Self-asserted source
Ferdinand Anton Weinelt

Works (11)

Results from a Joined Prospective Study to Evaluate the Sensitivity of the In Vivo Dog QT Assay in Line with the ICH E14/S7B Q&A Best Practices

Clinical Pharmacology & Therapeutics
2024-07 | Journal article
Part of ISSN: 0009-9236
Part of ISSN: 1532-6535
Contributors: Anne‐Marie Bétat; Annie Delaunois; Eric DELPY; Mathilde Loiseau; Anne Maurin; Gwendoline Poizat; Celine Possémé; Ferdinand Weinelt; Christophe Drieu la Rochelle; Eric Martel et al.
Source: Self-asserted source
Ferdinand Anton Weinelt

Addressing the ADME Challenges of Compound Loss in a PDMS-Based Gut-on-Chip Microphysiological System

Pharmaceutics
2024-02-20 | Journal article
Contributors: Patrick Carius; Ferdinand Anton Weinelt; Chris Cantow; Markus Holstein; Aaron M. Teitelbaum; Yunhai Cui
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

Antimicrobial Agents and Chemotherapy
2023-05 | Journal article
Contributors: Lea Marie Schatz; Alexander Brinkmann; Anka Röhr; Otto Frey; Sebastian Greppmair; Ferdinand Weinelt; Michael Zoller; Christina Scharf; Georg Hempel; Uwe Liebchen
Source: check_circle
Crossref

Does the cytokine adsorber CytoSorb® reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study

Annals of Intensive Care
2022-12 | Journal article
Part of ISSN: 2110-5820
Source: Self-asserted source
Ferdinand Anton Weinelt

Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools

Antibiotics
2022-06-02 | Journal article
Contributors: Ferdinand Anton Weinelt; Miriam Songa Stegemann; Anja Theloe; Frieder Pfäfflin; Stephan Achterberg; Franz Weber; Lucas Dübel; Agata Mikolajewska; Alexander Uhrig; Peggy Kiessling et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Combination of Pharmacokinetic and Pathogen Susceptibility Information To Optimize Meropenem Treatment of Gram-Negative Infections in Critically Ill Patients

Antimicrobial Agents and Chemotherapy
2022-02-15 | Journal article
Contributors: Uwe Liebchen; Ferdinand Weinelt; Christina Scharf; Ines Schroeder; Michael Paal; Michael Zoller; Charlotte Kloft; Jette Jung; Robin Michelet
Source: check_circle
Crossref

Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing—A Translational Example for Intensive Care Units

Pharmaceutics
2021-12-10 | Journal article
Contributors: Ferdinand Anton Weinelt; Miriam Songa Stegemann; Anja Theloe; Frieder Pfäfflin; Stephan Achterberg; Lisa Schmitt; Wilhelm Huisinga; Robin Michelet; Stefanie Hennig; Charlotte Kloft
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

No clinically relevant removal of meropenem by cytokine adsorber CytoSorb® in critically ill patients with sepsis or septic shock

Intensive Care Medicine
2021-11 | Journal article
Part of ISSN: 0342-4642
Part of ISSN: 1432-1238
Source: Self-asserted source
Ferdinand Anton Weinelt

Target Site Pharmacokinetics of Meropenem: Measurement in Human Explanted Lung Tissue by Bronchoalveolar Lavage, Microdialysis, and Homogenized Lung Tissue

Antimicrobial Agents and Chemotherapy
2021-11-17 | Journal article
Part of ISSN: 0066-4804
Part of ISSN: 1098-6596
Source: Self-asserted source
Ferdinand Anton Weinelt

CYP2D6 phenotype explains reported yohimbine concentrations in four severe acute intoxications

Archives of Toxicology
2021-05-24 | Journal article
Part of ISSN: 0340-5761
Part of ISSN: 1432-0738
Source: Self-asserted source
Ferdinand Anton Weinelt

Evaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill Patients

Antibiotics
2021-04 | Journal article | Author
Contributors: Uwe Liebchen; Marian Klose; Michael Paal; Michael Vogeser; Michael Zoller; Ines Schroeder; Lisa Schmitt; Wilhelm Huisinga; Robin Michelet; Johannes Zander et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute